cyclosporine has been researched along with Epithelial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuoka, J; Fukuoka, M; Funaki, S; Hasegawa, Y; Ishikawa, Y; Kurosaki, T; Mukai, K; Okimura, A; Ota, T; Sano, H; Wada, Y | 1 |
| Coveñas, R; González, A; Muñoz, M; Rosso, M; Saenz, J | 1 |
2 other study(ies) available for cyclosporine and Epithelial Neoplasms
| Article | Year |
|---|---|
Disappearance of recurrent thymic epithelial tumor following corticosteroid and cyclosporine treatment: A case report.
Topics: Adrenal Cortex Hormones; Cyclosporine; Humans; Neoplasms, Glandular and Epithelial; Thymus Neoplasms | 2022 |
The broad-spectrum antitumor action of cyclosporin A is due to its tachykinin receptor antagonist pharmacological profile.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Cyclosporine; HEK293 Cells; Humans; Immunosuppressive Agents; Inhibitory Concentration 50; Neoplasms, Glandular and Epithelial; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Receptors, Tachykinin; Substance P | 2010 |